FDA's final NDI guidance sets identity and safety expectations. See what AHPA and CRN say remains unresolved and what it means for suppliers.
Alicia Bigica
Advertisement
Alicia Bigica is Vice President of Content at MJH Life Sciences.
Articles by Alicia Bigica
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
Lonza Capsugel to Feature Organicaps, UC-II, and Capsule Delivery Technologies at SupplySide Global 2026
2
FDA Finalizes NDI Guidance on Identity and Safety Information, Leaving Some Industry Concerns Open
3
Full-Spectrum Curcumin Extract from DolCas Enters Two New Formats at SupplySide Global 2026
4
EFSA Outlines Scientific Priorities Ahead of Its 2027 Strategy
5